Multiple Sclerosis program for patients

Aligned Educational Series in Multiple Sclerosis – Live This Summer

PlatformQ Health is pleased to announce a three-part educational series for the clinicians treating and families facing multiple sclerosis (MS), created in collaboration with the National Multiple Sclerosis Society (NMSS) and the Consortium of Multiple Sclerosis Centers (CMSC). On June 20, 2019, two special programs will be streamed live – one created especially for clinicians, […]

Read More

American Academy of Neurology Annual Meeting

Neurological Rare Diseases Front & Center in PlatformQ Health Poster Sessions at AAN 2019

PlatformQ Health is pleased to announce our education team will present three poster sessions at this year’s Annual Meeting of the American Academy of Neurology (AAN), which will share insights from recent educational series in neurological diseases, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Lennox-Gastaut Syndrome, and Multiple Sclerosis (MS). “We have a long track record of […]

Read More

hATTR Amyloidosis CME

Overview of hATTR Amyloidosis: New CME

Join our experts for a one-hour CME presentation as they appraise clinical safety and efficacy data for new and emerging therapeutic agents for the treatment of hATTR amyloidosis.    hATTR amyloidosis is a genetic disorder that is characterized by the deposition of amyloid (abnormal proteins) in multiple organs. It often affects the nerves, liver, heart […]

Read More

Multiple Sclerosis (MS) CME

Recent advances in the knowledge of brain pathology in Multiple Sclerosis patients

Multiple sclerosis (MS) is a complicated demyelinating disease of the central nervous system, where patients experience a great range of symptoms due to demyelination of nerve fibers. It is characterized by plaques in the brain and spinal fluid. Symptoms that have been observed include numbness, diplopia, cognitive impairment, paralysis, blindness, fatigue, and bladder dystonia. [1] […]

Read More

PlatformQ Health presents at American Academy of Neurology

Rare Disease, Migraine and MS Front and Center at AAN

PlatformQ Health was proud to present two posters – a traditional poster and an e-poster – at this year’s Annual Meeting of the American Academy of Neurology (AAN). Alongside VP of Education Jayne Chaplick, Senior Medical Director Anne Roc attended to present the posters, which focus on insights from previous PQH educational initiatives. While at […]

Read More

woman crying by bed

Pseudobulbar Affect (PBA): Diagnosis in the Midst of Depression

Pseudobulbaa affect (PBA) typically presents as episodes of uncontrollable laughing or crying that is out of context to the current social situation. The patient’s emotional expression is incongruent to their emotional state. Usually, PBA is seen in the setting of other neurologic diseases such as ALS, Parkinson’s disease, Alzeihmer’s dementia, stroke, progressive MS, brain tumors, […]

Read More

sport concussion

Concussion in Children: Returning to Play

In my practice, I see it frequently that a coach allowed a patient to return to play after suffering a concussion and still symptomatic. The popular movie, “Concussion” starring Will Smith, brought to light the grave damage recurrent concussions can cause on the brain to the general American population. Yet, for some, the future neurological […]

Read More

pediatric epilepsy

Pediatric Epilepsy: From early childhood through adolescence

In this CME offering from NeuroSeriesLive, Dr. Dennis Dlugos takes viewers through the current best practices for pediatric epilepsy. Using two case studies, Dr. Dlugos discusses diagnosis challenges and considerations, goals and concerns of medication treatments, and offers several non-medical treatment options. Dr. Dlugos, Professor of Neurology and Pediatrics at the Perelman School of Medicine […]

Read More

migraine treatment CME

Acute Migraine Treatment Choices

Migraine headaches are a debilitating collection of neurological symptoms often accompanied by one or more of the following: visual disturbances, nausea, vomiting, dizziness, extreme sensitivity to sound, light, touch, and smell, and tingling or numbness in the extremities or face. A common disorder, about 30 million people in America suffer from this condition to varying […]

Read More

Migraine CME

Migraine Symposium: Migraine Treatment Options

NeuroSeriesLive and Jefferson Headache Center announce their upcoming event about migraine treatments, which is entitled “Treatment Choices in Acute Migraine Management: Selecting Appropriate Use for Individual Patients.” The interactive online CME session includes Stephen D. Silberstein, MD and Michael J. Marmura, MD from the Center. Dr. Silberstein, the Director of the Jefferson Headache Center, Thomas […]

Read More

Multiple Sclerosis (MS) CME

Multiple Sclerosis (MS) Treatment Options

As a result of ongoing research, more treatment choices in MS care are available than ever before. In this video, “Treatment Choices in MS Care: Which is the Correct Disease-Modifying Therapy?,” Drs. Lisak and Cohen discuss the benefits and risks of several DMTs. Using results from clinical trials, MRI data, and discussion around case studies, […]

Read More

multiple sclerosis

Updates in Multiple Sclerosis Management: ECTRIMS 2015

The 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, held October 7 through October 10, 2015, in Barcelona, Spain, featured presentations on personalized therapies, updated clinical trials, risk management, and therapeutic strategies for multiple sclerosis treatments. The treatments are likely to be ones doctors will explore for changing […]

Read More

epilepsy

Epilepsy Quality Measures

The 2014 update to the Centers for Medicare & Medicaid Services’ (CMS) Epilepsy Quality Measures focuses on seven guidelines that have a greater emphasis on recording and intervention than the previous 2009 measures, according to medical experts in “Adhering to the Epilepsy Quality Measurement Set Update,” a CME video presentation for the virtual education summit […]

Read More

lennox gastaut syndrome

Identifying and Treating Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome is a form of childhood epilepsy that requires careful diagnosis, treatment and transitional management into adulthood. In “Lennox-Gastaut Syndrome Across the Lifespan: Improving Diagnosis and Management,” a presentation from NeuroSeriesLive, experts Gregory L. Krauss, MD, from Johns Hopkins School of Medicine, and John M. Pellock, MD, at Virginia Commonwealth University discuss the condition […]

Read More

alzheimers

Alzheimer’s Diagnosis and Management

After more than three decades of using the same diagnostic criteria, recent research yielded a new set of standards for Alzheimer’s diagnosis. This new criteria impacts treatment strategies and offers hope for improving patient outcomes, according to medical experts in “Alzheimer’s Disease in 2015: Diagnosis and Management Across the Disease Spectrum,” a CME video presentation […]

Read More

lennox gastaut syndrome CME

Lennox-Gastaut Syndrome (LGS) Across the Lifespan

Lennox-GastautSyndrome (LGS) Virtual CME Symposium Live, Complimentary Online Medical Education Wednesday, November 4, 2015 from 11:00 am – 12:00 noon ET Featured Speakers Gregory L. Krauss, MD Johns Hopkins School of Medicine John M. Lellock, MD Virginia Commonwealth University   Topics include Disease characteristics that may suggest a patient has LGS Differences associated with LGS […]

Read More

Dementia CME

Understanding Dementia: A Physician Q&A

Our recent event, “New Direction in the Assessment and Management of Patients with Alzheimer’s Disease” was a success with several hundred doctors attending the interactive online broadcast. We compiled a Q&A section of questions from clinicians about the latest treatments, diagnostic options, and other related questions about dementia and Alzheimer’s. Dementia Treatment and Diagnostic Options […]

Read More